Pharmaceutical / Drug Definition :
Inhibits calcium from entering myocardial and vascular smooth-muscle cells, thereby depressing myocardial and smooth-muscle contraction and decreasing impulse formation and conduction velocity. As a result, systolic and diastolic pressures decrease.
FDA Label Requirements and Exceptions
Diltiazem Hydrochloride
FDA Import Information
Diltiazem Hydrochloride
FDA Detentions
Diltiazem Hydrochloride (Diltiazem Hydrochloride Entry Refusal)
General U.S. Food and Drug Administration Guidelines for:
- Manufacturers Diltiazem Hydrochloride (Diltiazem Hydrochloride Suppliers)
- Processors Diltiazem Hydrochloride
- Repackers Diltiazem Hydrochloride
- Relabelers Diltiazem Hydrochloride
- Exporters Diltiazem Hydrochloride
- Importers Diltiazem Hydrochloride
For more information about Diltiazem Hydrochloride, simply click below:
U.S. FDA Regulations:
U.S. FDA Regulation: 21 C.F.R. Part 207
Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.
